How much is the Heparin Market market?

The heparin market market size is estimated to grow at $$ 3.34 bn in 2023. Read More

What is the growth rate of the Heparin Market market?

The growth rate of the heparin market year-over-year is 7.22%. Read More

Which region held the largest market share in the Heparin Market market?

Europe is the region to held the largest market share with 34% growth. Read More

Who are the key players in the Heparin Market market?

Aspen Pharmacare Holdings Ltd, B.Braun SE, Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hebei Changshan Biochemical, .... Read More

Which Segment has the largest market share in the Heparin Market market?

Product is the segment that has the largest market share in the market. Read More

Heparin Market Analysis Europe, North America, Asia, Rest of World (ROW) - US, UK, Germany, France, China - Size and Forecast 2024-2028

Published: Nov 2023
Pages: 165
SKU: IRTNTR40831

Enjoy complimentary customisation on priority with our Enterprise License!

Heparin Market Size 2024-2028

The heparin market size is forecast to increase by USDUSD 3.34 billion at a CAGR of 7.22% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of coagulation disorders, particularly in populations with chronic conditions such as cancer, diabetes and types , and chronic respiratory diseases and chronic management. These conditions increase the risk of blood clots, making anticoagulants like heparin essential for preventing complications. Furthermore, the research and development (R&D) sector is actively exploring new therapeutic applications for heparin, expanding its use beyond traditional anticoagulation. However, the market also faces challenges, including potential side effects of heparin, such as bleeding risks and the need for frequent monitoring. Additionally, plasma-derived therapies (PDTs) are gaining popularity as alternatives to synthetic heparin, presenting competition for market players. Overall, the market is poised for continued growth, driven by increasing demand for effective coagulation management solutions.

What will be the Size of the Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global heparin market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global heparin market 2018 - 2022 ($ billion)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

4.3 Route Of Administration Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Route Of Administration Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Low-molecular-weight heparin - Market size and forecast 2023-2028
- Exhibit 34: Chart on Low-molecular-weight heparin - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Low-molecular-weight heparin - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Low-molecular-weight heparin - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2023-2028 (%)

6.4 Others - Market size and forecast 2023-2028
- Exhibit 38: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ billion)
- Exhibit 43: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)

7.2 Comparison by Route of Administration
- Exhibit 46: Chart on Comparison by Route of Administration
- Exhibit 47: Data Table on Comparison by Route of Administration

7.3 Subcutaneous injection - Market size and forecast 2023-2028
- Exhibit 48: Chart on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
- Exhibit 49: Data Table on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
- Exhibit 50: Chart on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Subcutaneous injection - Year-over-year growth 2023-2028 (%)

7.4 Intravenous infusion - Market size and forecast 2023-2028
- Exhibit 52: Chart on Intravenous infusion - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Intravenous infusion - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Intravenous infusion - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Intravenous infusion - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Route of Administration
- Exhibit 56: Market opportunity by Route of Administration ($ billion)
- Exhibit 57: Data Table on Market opportunity by Route of Administration ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 Europe - Market size and forecast 2023-2028
- Exhibit 63: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 64: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.4 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 UK - Market size and forecast 2023-2028
- Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 China - Market size and forecast 2023-2028
- Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)

9.11 France - Market size and forecast 2023-2028
- Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ billion)
- Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 Aspen Pharmacare Holdings Ltd
- Exhibit 107: Aspen Pharmacare Holdings Ltd - Overview
- Exhibit 108: Aspen Pharmacare Holdings Ltd - Business segments
- Exhibit 109: Aspen Pharmacare Holdings Ltd - Key offerings
- Exhibit 110: Aspen Pharmacare Holdings Ltd - Segment focus

12.4 B.Braun SE
- Exhibit 111: B.Braun SE - Overview
- Exhibit 112: B.Braun SE - Business segments
- Exhibit 113: B.Braun SE - Key news
- Exhibit 114: B.Braun SE - Key offerings
- Exhibit 115: B.Braun SE - Segment focus

12.5 Baxter International Inc.
- Exhibit 116: Baxter International Inc. - Overview
- Exhibit 117: Baxter International Inc. - Business segments
- Exhibit 118: Baxter International Inc. - Key news
- Exhibit 119: Baxter International Inc. - Key offerings
- Exhibit 120: Baxter International Inc. - Segment focus

12.6 Eisai Co. Ltd.
- Exhibit 121: Eisai Co. Ltd. - Overview
- Exhibit 122: Eisai Co. Ltd. - Business segments
- Exhibit 123: Eisai Co. Ltd. - Key offerings
- Exhibit 124: Eisai Co. Ltd. - Segment focus

12.7 Fresenius SE and Co. KGaA
- Exhibit 125: Fresenius SE and Co. KGaA - Overview
- Exhibit 126: Fresenius SE and Co. KGaA - Business segments
- Exhibit 127: Fresenius SE and Co. KGaA - Key news
- Exhibit 128: Fresenius SE and Co. KGaA - Key offerings
- Exhibit 129: Fresenius SE and Co. KGaA - Segment focus

12.8 Hikma Pharmaceuticals Plc
- Exhibit 130: Hikma Pharmaceuticals Plc - Overview
- Exhibit 131: Hikma Pharmaceuticals Plc - Business segments
- Exhibit 132: Hikma Pharmaceuticals Plc - Key offerings
- Exhibit 133: Hikma Pharmaceuticals Plc - Segment focus

12.9 Laboratorios Farmaceuticos ROVI S A
- Exhibit 134: Laboratorios Farmaceuticos ROVI S A - Overview
- Exhibit 135: Laboratorios Farmaceuticos ROVI S A - Business segments
- Exhibit 136: Laboratorios Farmaceuticos ROVI S A - Key offerings
- Exhibit 137: Laboratorios Farmaceuticos ROVI S A - Segment focus

12.10 Nanjing Kingfriend Biochemical
- Exhibit 138: Nanjing Kingfriend Biochemical - Overview
- Exhibit 139: Nanjing Kingfriend Biochemical - Product / Service
- Exhibit 140: Nanjing Kingfriend Biochemical - Key offerings

12.11 Nichi Iko Pharmaceutical Co. Ltd.
- Exhibit 141: Nichi Iko Pharmaceutical Co. Ltd. - Overview
- Exhibit 142: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 143: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings

12.12 Novartis AG
- Exhibit 144: Novartis AG - Overview
- Exhibit 145: Novartis AG - Business segments
- Exhibit 146: Novartis AG - Key offerings
- Exhibit 147: Novartis AG - Segment focus

12.13 Pfizer Inc.
- Exhibit 148: Pfizer Inc. - Overview
- Exhibit 149: Pfizer Inc. - Product / Service
- Exhibit 150: Pfizer Inc. - Key news
- Exhibit 151: Pfizer Inc. - Key offerings

12.14 Sanofi SA
- Exhibit 152: Sanofi SA - Overview
- Exhibit 153: Sanofi SA - Business segments
- Exhibit 154: Sanofi SA - Key news
- Exhibit 155: Sanofi SA - Key offerings
- Exhibit 156: Sanofi SA - Segment focus

12.15 Shenzhen Techdow Pharmaceutical
- Exhibit 157: Shenzhen Techdow Pharmaceutical - Overview
- Exhibit 158: Shenzhen Techdow Pharmaceutical - Product / Service
- Exhibit 159: Shenzhen Techdow Pharmaceutical - Key offerings

12.16 Teva Pharmaceutical Industries Ltd.
- Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus

12.17 Viatris Inc.
- Exhibit 165: Viatris Inc. - Overview
- Exhibit 166: Viatris Inc. - Business segments
- Exhibit 167: Viatris Inc. - Key news
- Exhibit 168: Viatris Inc. - Key offerings
- Exhibit 169: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 170: Inclusions checklist
- Exhibit 171: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 172: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 173: Research methodology
- Exhibit 174: Validation techniques employed for market sizing
- Exhibit 175: Information sources